Heart attack test gets a Tune-Up: new method aims to cut false positives

NCT ID NCT04465591

Recruiting now Diagnosis Sponsor: University of Turku Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new way to analyze blood samples to see if it can better tell when someone is having a heart attack. Current tests can be misleading in patients with other conditions like kidney failure. Researchers will look at how troponin T, a protein released during heart injury, breaks down into fragments. The goal is to see if the fragmentation pattern can help doctors make a more accurate diagnosis. The study will enroll 1,500 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: troponin T fragmentation test (blood test)
What this could lead to: If successful, this test could help doctors more accurately diagnose heart attacks and avoid false alarms from other conditions like kidney disease.
What could go wrong: This is an early observational study, so the test may not prove reliable enough for routine use. It is not a treatment and will not directly improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYOCARDIAL INFARCTION TYPE 1 MYOCARDIAL INJURY

Contacts and locations

Locations

Turku University Hospital, Heart Center
RECRUITING

Turku, Southwest Finland, 20521, Finland
University Hospital Zurich
ENROLLING_BY_INVITATION

Zurich, 8091 Zurich, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.